Corticosteroids for pain relief in sore throat: systematic review and meta-analysis
BMJ 2009; 339 doi: https://doi.org/10.1136/bmj.b2976 (Published 06 August 2009) Cite this as: BMJ 2009;339:b2976All rapid responses
Rapid responses are electronic comments to the editor. They enable our users to debate issues raised in articles published on bmj.com. A rapid response is first posted online. If you need the URL (web address) of an individual response, simply click on the response headline and copy the URL from the browser window. A proportion of responses will, after editing, be published online and in the print journal as letters, which are indexed in PubMed. Rapid responses are not indexed in PubMed and they are not journal articles. The BMJ reserves the right to remove responses which are being wilfully misrepresented as published articles or when it is brought to our attention that a response spreads misinformation.
From March 2022, the word limit for rapid responses will be 600 words not including references and author details. We will no longer post responses that exceed this limit.
The word limit for letters selected from posted responses remains 300 words.
The title and text of this review use only the plural
"corticosteroids": but of course each patient in the trials included
received only one corticosteroid. Use of the plural suggests from the
start that differences between corticosteroids are irrelevant or at least
unimportant, but the paper does not consider this point - it should.
Six of the 8 trials reviewed used dexamethasone, one betamethasone,
one prednisone. What differences might have been looked for between the
effects of these three drugs? What did the trial reports state about
adverse events? Seemingly only Kidman et al [w5] noted any. The reviewers
should surely have remarked on this inadequacy.
They also don't say openly what they themselves would now do for a
patient with a painful sore throat; I suppose they would favour a single
oral dose of dexamethasone - while virtuously waiting for more evidence
and 'generalisability'. But the question doesn't seem quite important
enough for trials to be funded in Europe.
How were the eight reviewed trials funded?
Competing interests:
None declared
Competing interests: No competing interests
Erratum
Sir, It was interesting to read the meta-analysis and systematic
review on the use of corticosteroids for pain relief in sore throat. I
would like to point out an error in this article in figure 4 (Effect of
corticosteroids on mean time to onset of pain relief analysed by subgroup
using meta-regression.), where the statistical values [(I2, Trials (n),
Patients(n), Interaction, Weighted mean difference (random)(95% CI)] for
bacterial pathogen positive and bacterial pathogen negative cases have
been interchanged. This will become more apparent if you read the second
paragraph under the subheading ‘Mean time to onset of pain relief' in the
results section.
Competing interests:
None declared
Competing interests: No competing interests